Neurodevelopmental disorders in children born to mothers with systemic lupus erythematosus

Lupus

Volumn 23, Issue 11, 2014, Pages 1099-1104

  Vinet, E ^a,b   Pineau, C A ^b   Clarke, A E ^c   Fombonne, E ^d   Platt, R W ^e   Bernatsky, S ^a,b  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Neurodevelopmental disorders; Pregnancy; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CYTOKINE; MATERNAL ANTIBODY;

ADVERSE OUTCOME; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; AUTOIMMUNE DISEASE; BRAIN DEVELOPMENT; BRAIN SIZE; CASE CONTROL STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DSM-IV; FETUS DEVELOPMENT; GENETIC ASSOCIATION; HUMAN; LOW BIRTH WEIGHT; MATERNAL OBESITY; MATERNAL SMOKING; MOTHER; NONHUMAN; PARENTAL AGE; PREFRONTAL CORTEX; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROGENY; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; CHILD; COMPLICATION; DEVELOPMENTAL DISABILITIES; DISEASE MODEL; FEMALE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; RISK FACTOR;

ANIMALS; AUTOANTIBODIES; CHILD; CYTOKINES; DEVELOPMENTAL DISABILITIES; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

EID: 84928138238     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314541691     Document Type: Article

References (49)

1. Faraone SV, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry 2003; 2: 104-113.
2. Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators; Centers for Disease Control and Prevention (CDC). Prevalence of autism spectrum disorder among children aged 8 years-autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ 2014; 63: 1-21.
3. Lahita RG. Systemic lupus erythematosus: Learning disability in the male offspring of female patients and relationship to laterality. Psychoneuroendocrinology 1988; 13: 385-396.
4. McAllister DL, Kaplan BJ, Edworthy SM, et al. The influence of systemic lupus erythematosus on fetal development: Cognitive, behavioral, and health trends. J Int Neuropsychol Soc 1997; 3: 370-376.
5. Neri F, Chimini L, Bonomi F, et al. Neuropsychological development of children born to patients with systemic lupus erythematosus. Lupus 2004; 13: 805-811.
6. Ross G, Sammaritano L, Nass R, Lockshin M. Effects of mothers' autoimmune disease during pregnancy on learning disabilities and hand preference in their children. Arch Pediatr Adolesc Med 2003; 157: 397-402.
7. Urowitz MB, Gladman DD, MacKinnon A, et al. Neurocognitive abnormalities in offspring of mothers with systemic lupus erythematosus. Lupus 2008; 17: 555-560.
8. Marder W, Ganser MA, Romero V, et al. In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2013; 65: 759-766.
9. Braunschweig D, VandeWater J. Maternal autoantibodies in autism. Arch Neurol 2012; 69: 693-699.
10. Wang L, Zhou D, Lee J, et al. Female mouse fetal loss mediated by maternal autoantibody. J Exp Med 2012; 209: 1083-1089.
11. Smith SE, Li J, Garbett K, Mirnics K, Patterson PH. Maternal immune activation alters fetal brain development through interleukin- 6. J Neurosci 2007; 27: 10695-10702.
12. Naves M, Hajeer AH, Teh LS, et al. Complement C4B null allele status confers risk for systemic lupus erythematosus in a Spanish population. Eur J Immunogenet 1998; 25: 317-320.
13. Warren RP, Singh VK, Averett RE, et al. Immunogenetic studies in autism and related disorders. Mol Chem Neuropathol 1996; 28: 77-81.
14. Odell D, Maciulis A, Cutler A, et al. Confirmation of the association of the C4B null allelle in autism. Hum Immunol 2005; 66: 140-145.
15. Thapar A, Cooper M, Jefferies R, Stergiakouli E. What causes attention deficit hyperactivity disorder? Arch Dis Child 2012; 97: 260-265.
16. Lampi KM, Lehtonen L, Tran PL, et al. Risk of autism spectrum disorders in low birth weight and small for gestational age infants. J Pediatr 2012; 161: 830-836.
17. Bromley RL, Mawer G, Clayton-Smith J, Baker GA; Liverpool and Manchester Neurodevelopment.
18. Raviola G, Gosselin GJ, Walter HJ, DeMaso DR. Pervasive developmental disorders and childhood psychosis. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF (eds), Nelson textbook of pediatrics, 19th ed. Philadelphia: Saunders Elsevier, 2011. p. 28.
19. Cunningham NR, Jensen P. Attention-Deficit/Hyperactivity Disorder. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF (eds), Nelson textbook of pediatrics, 19th ed. Philadelphia: Saunders Elsevier, 2011. p. 30.
20. Sperner-Unterweger B. Immunological aetiology of major psychiatric disorders: Evidence and therapeutic implications. Drugs 2005; 65: 1493-1520.
21. Nopoulos P, Berg S, Castellenos FX, Delgado A, Andreasen NC, Rapoport JL. Developmental brain anomalies in children with attention-deficit hyperactivity disorder. J Child Neurol 2000; 15: 102-108.
22. Hoeft F, Walter E, Lightbody AA, et al. Neuroanatomical differences in toddler boys with fragile x syndrome and idiopathic autism. Arch Gen Psychiatry 2011; 68: 295-305.
23. Kalkbrenner AE, Braun JM, Durkin MS, et al. Maternal smoking during pregnancy and the prevalence of autism spectrum disorders, using data from the autism and developmental disabilities monitoring network. Environ Health Perspect 2012; 120: 1042-1048.
24. Askanase AD, Izmirly PM, Katholi M, Mumtaz J, Buyon JP. Frequency of neuro-psychiatric dysfunction in anti-SSA/SSB exposed children with and without neonatal lupus. Lupus 2010; 19: 300-306.
25. Mekinian A, Lachassinne E, Nicaise-Roland P, et al. European registry of babies born to mothers with antiphospholipid syndrome. Ann Rheum Dis 2013; 72: 217-222.
26. Nacinovich R, Galli J, Bomba M, et al. Neuropsychological development of children born to patients with antiphospholipid syndrome. Arthritis Rheum 2008; 59: 345-351.
27. Abisror N, Mekinian A, Lachassinne E, et al. Outcome of babies born to mothers with systemic auto-immune diseases [abstract]. Arthritis Rheum 2011; 63(Suppl 10): 2035.
28. Atladóttir HO, Pedersen MG, Thorsen P, et al. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 2009; 124: 687-694.
29. Sweeten TL, Bowyer SL, Posey DJ, Halberstadt GM, McDougle CJ. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 2003; 112: e420.
30. Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 1999; 14: 388-394.
31. Brucato A, Frassi M, Franceschini F, et al. Risk of complete congenital heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: A prospective study of 100 women. Arthritis Rheum 2001; 44: 1832-1835.
32. Benayed R, Gharani N, Rossman I, et al. Support for the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder susceptibility locus. Am J Hum Genet 2005; 77: 851-868.
33. Singer HS, Morris C, Gause C, Pollard M, Zimmerman AW, Pletnikov M. Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: A pregnant dam mouse model. J Neuroimmunol 2009; 211: 39-48.
34. Braunschweig D, Duncanson P, Boyce R, et al. Behavioral correlates of maternal antibody status among children with autism. J Autism Dev Disord 2012; 42: 1435-1445.
35. Brimberg L, Sadiq A, Gregersen PK, Diamond B. Brain-reactive IgG correlates with autoimmunity in mothers of a child with an autism spectrum disorder. Mol Psychiatry 2013; 18: 1171-1177.
36. Lee JY, Huerta PT, Zhang J, et al. Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat Med 2009; 15: 91-96.
37. Vinet É, Bernatsky S, Pineau CA, et al. Increased male-to-female ratio in children born to women with systemic lupus erythematosus. Arthritis Rheum 2013; 65: 1129.
38. Tarabeux J, Kebir O, Gauthier J, et al. Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia. Transl Psychiatry 2011; 1: e55.
39. Dorval KM, Wigg KG, Crosbie J, et al. Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain Behav 2007; 6: 444-452.
40. Pozzi L, Baviera M, Sacchetti G, et al. Attention deficit induced by blockade of N-methyl D-aspartate receptors in the prefrontal cortex is associated with enhanced glutamate release and cAMP response element binding protein phosphorylation: Role of metabotropic glutamate receptors 2/3. Neuroscience 2011; 176: 336-348.
41. Won H, Lee HR, Gee HY, et al. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 2012; 486: 261-265.
42. Bangash MA, Park JM, Melnikova T, et al. Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism. Cell 2011; 145: 758-772.
43. Moskal JR, Burgdorf J, Kroes RA, Brudzynski SM, Panksepp J. A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism. Neurosci Biobehav Rev 2011; 35: 1982-1988.
44. Caronti B, Calderaro C, Alessandri C, et al. Serum anti-beta2- glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells. J Autoimmun 1998; 11: 425-429.
45. Shrot S, Katzav A, Korczyn AD, et al. Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies. Lupus 2002; 11: 736-743.
46. Tsokos GC. Systemic lupus erythematosus. N Engl J Med 2011; 365: 2110-2121.
47. Cortés-Hernández J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: A prospective study of 103 pregnancies. Rheumatology 2002; 41: 643-650.
48. Petri M, Allbriton J. Fetal outcome of lupus pregnancy: A retrospective case-control study of the Hopkins Lupus Cohort. J Rheumatol 1993; 20: 650-656.
49. Molad Y, Borkowski T, Monselise A, et al. Maternal and fetal outcome of lupus pregnancy: A prospective study of 29 pregnancies. Lupus 2005; 14: 145-151.